Bortezomib and Filgrastim to Promote Stem Cell Mobilization in Patients With Non-Hodgkin Lymphoma or Multiple Myeloma
Clinical trial NCT02037256 · COMPLETED
Trial details
- NCT number
- NCT02037256
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2011-07-01
- Primary completion
- 2015-01-21
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.